Thrombophlebitis associated with vitamin E therapy. With a commentary on other medical side effects.
I have encountered 50 patients with clinical thrombophlebitis involving the lower extremites, with or without associated edema and pulmonary embolism, in whom longstanding self-medication with large amounts of vitamin E appeared to be a significant factor. The majority improved following cessation of vitamin E. In view of the epidemic nature of thrombophlebitis and deep vein thrombosis in the United States, the presumed innocuousness of vitamin E therapy requires reevaluation. Other clinical side effects also have been noted in patients receiving large doses of vitamin E. They include breast tenderness, elevation of blood pressure, a fatigue syndrome, myopathy, intestinal cramps, urticaria, and the possible aggravation of diabetes mellitus. The influence of concomitant metabolic, endocrine, and cardiovascular disorders on the thrombogenic potential of vitamin E is raised, and several possible mechanisms conducive to thrombophlebitis are reviewed.
D000328:Adult; D000368:Aged; D001941:Breast Diseases / Q000139:chemically induced; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced* / Q000175:diagnosis; D014810:Vitamin E / Q000009:adverse effects*
D004967:Estrogens; D014810:Vitamin E